CHHE (China Health Industries Holdings) Net Current Asset Value: $-0.10 (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHHE China Health Industries Holdings Inc CHHE
20 GF Score
Price $0.00
View Full Analysis

What is China Health Industries Holdings Net Current Asset Value?

China Health Industries Holdings CHHE 20 Net Current Asset Value is $-0.10 as of Mar. 2024. GuruFocus rates CHHE with a GF Score™ of 20/100.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

China Health Industries Holdings's net current asset value per share for the quarter that ended in Mar. 2024 was $-0.10.

The historical rank and industry rank for China Health Industries Holdings's Net Current Asset Value or its related term are showing as below:

CHHE's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.72
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

China Health Industries Holdings  (OTCPK:CHHE) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


China Health Industries Holdings Net Current Asset Value Related Terms


China Health Industries Holdings Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for China Health Industries Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Industries Holdings Net Current Asset Value Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.51 0.59 0.57 0.53

China Health Industries Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.53 0.53 -0.10 -0.10

CHHE vs BIOE, CRYM, TXMD: Net Current Asset Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings Price-to-Net-Current-Asset-Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's Price-to-Net-Current-Asset-Value falls into.


CHHE
20GF Score
China Health Industries Holdings Inc CHHE
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Industries Holdings Net Current Asset Value Calculation

China Health Industries Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Jun. 2023 is calculated as

Net Current Asset Value Per Share(A: Jun. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(40.97-5.973-0-0)/65.540
=0.53

China Health Industries Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2024 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.248-6.529-0-0)/65.540
=-0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of $-0.10 mean?
China Health Industries Holdings (CHHE) has a Net Current Asset Value of $-0.10 as of Mar. 2024. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on China Health Industries Holdings and its competitors.
Is China Health Industries Holdings' Net Current Asset Value too high?
China Health Industries Holdings' current Net Current Asset Value is $-0.10. Overall, China Health Industries Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does China Health Industries Holdings' Net Current Asset Value compare to BIOE and CRYM?
China Health Industries Holdings' Net Current Asset Value of $-0.10 can be compared against companies in the Drug Manufacturers industry. The industry median Net Current Asset Value is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Drug Manufacturers company?
The median Net Current Asset Value among Drug Manufacturers companies is 5.72, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on China Health Industries Holdings and its competitors. For the Drug Manufacturers industry, the median Net Current Asset Value is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Industries Holdings's current Net Current Asset Value is $-0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Industries Holdings stock overvalued right now?
China Health Industries Holdings (CHHE) has a current Net Current Asset Value of $-0.10. The current Net Current Asset Value is $-0.10. China Health Industries Holdings' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For China Health Industries Holdings (CHHE), the current Net Current Asset Value is $-0.10 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China Health Industries Holdings Business Description

Address 3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
20GF Score

Get the complete analysis for CHHE

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price